Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
C8 dihydro Ceramide is a sphingolipid and an intermediate in the synthesis of C8 ceramide (Item No. 62540).1 It is synthesized by the acylation of sphinganine by ceramide synthase, a process that can be inhibited by some fungal mycotoxins, such as fumonisin B1 (Item No. 62580).2 C8 dihydro Ceramide can be converted to C8 ceramide via the introduction of a 4,5-trans double bond by dihydroceramide desaturase.1 C8 dihydro ceramide is metabolically inactive and has been used as a negative control for the biological activity of C8 ceramide.3 [Matreya, LLC. Catalog No. 1854]
WARNING This product is not for human or veterinary use.
1. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-
2. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. The Journal of Biological Chemisty 266(22), 14486-14490 (1991).
3. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. J. Pharmacol. Exp. Ther. 309(2), 523-532 (2004).